Open Access Pub publishes peer-reviewed, free-to-read open-access articles. Showing
articles matching medication — open any to read the full text,
or download the PDF or XML.
Dec 2015 DOI 10.14302/issn.2474-9273.jbtm-15-794
Mei-Hue WeiCorresponding author
The French physician, Gill de la Tourette, was the first person to define Tourette’s Syndrome (TS) in 1885 and has brought much attention to it in Western countries for the past few decades. Unfortunately, most Asian countries are not familiar with Tourette’s Syndrome. Tourette’s Syndrome is regarde…
Aug 2015 DOI 10.14302/issn.2372-6601.jhor-15-667
CL Cowan JrCorresponding author
Trichomegaly is a known adverse effect with the epidermal growth factor receptor inhibitor (EGFRI) and prostaglandin analogue drug classes. We present a chronic Latanoprost user who developed symptomatic trichomegaly subsequent to initiating an EGFRI medication and believe this case offers evidence…
Jun 2015 DOI 10.14302/issn.2471-2140.jaa-14-616
E.A. MilwardCorresponding author
Age-related macular degeneration (AMD) is responsible for a substantial proportion of severe visual impairment and blindness in people over 50 years of age. Current treatments for AMD are not effective in all patients and a proportion of patients who respond well to the treatment will still eventual…
Feb 2014 DOI 10.14302/issn.2324-7339.jcrhap-13-191
Pariya L. FazeliCorresponding author
Objective: This cross-sectional study examined cognitive subtypes and influential factors in HIV-positive (HIV+) adults. Method: Two-step cluster analysis was conducted on a neurocognitive test battery in a sample (N = 78) of adults and older adults with HIV (Mage = 46.1). Next, cognitive, functiona…
Nov 2013 DOI 10.14302/issn.2324-7339.jcrhap-13-304
Alexandria Garavaglia WilsonCorresponding author
Antiretrovirals have traditionally been associated with much toxicity. Newer antiretrovirals are considered much less toxic relative to older antiretrovirals. Upon its FDA-approval in 2009, raltegravir’s adverse drug reaction profile was found to be similar to placebo. However, recently there have b…